QURE

Bullish

uniQure Announces Preliminary Data on the First Cohort in

uniQure announced preliminary six-month data from the first cohort of its Phase I/IIa trial for AMT-260, an investigational gene therapy for refractor...

GlobeNewswire 1 week ago 0

Bullish

uniQure’s epilepsy gene therapy showed seizure drops in 3 patients

uniQure announced preliminary six-month data from the first, low-dose cohort of its Phase I/IIa trial for AMT-260, an investigational gene therapy for...

Stock Titan 1 week ago 0

Neutral

UniQure N.V. (QURE) files Rule 144 to sell 7,970 RSU shares on 06/11/2026

UniQure N.V. has filed a Rule 144 notice to sell 7,970 ordinary shares due to restricted stock unit vesting on June 11, 2026. The filing indicates Cit...

Stock Titan 2 weeks ago 0

Neutral

uniQure N.V. SEC Filing

This article reports a recent SEC Form 144 filing by uniQure N.V. (QURE) on June 11, 2026. The filing indicates a proposed sale of 1993 Ordinary Share...

Stock Titan 2 weeks ago 0